Please enable Javascript
Devalingam Mahalingam, PhD
Devalingam Mahalingam, PhD, Northwestern Feinberg School of Medicine
Articles by Devalingam Mahalingam, PhD
Elraglusib With Gem/Nab-Paclitaxel for Previously Untreated Metastatic Pancreatic Cancer
Devalingam Mahalingam, PhD
Pancreatic Cancer
|
June 2, 2025
Dr. Mahalingam shares preliminary results from the randomized phase 2 study of elraglusib with gemcitabine/nab-paclitaxel.
View More